The Latest Biology News And Medical NewsBiology News 2Health News 2Biology News 3Health News 3
HOME >> MEDICINE >> NEWS
Clinical trial shows drug may offer a new option to prevent rejection of transplanted kidneys

Results of a preliminary study suggest that a treatment called LEA29Y works as well as the standard therapy, cyclosporine, to prevent acute kidney transplant rejection, with less potential for long-term harm to the organ and the patient, and better functioning of the transplanted kidney.

LEA29Y is a new type of drug called a co-stimulatory blocker, which prevents the immune system from attacking the transplanted kidney in a more selective manner than traditional anti-rejection drugs. It blocks one of the two signals needed to activate T-cells, once they recognize the transplanted organ as foreign, but leaves the T-cells intact to fight off infections.

More than 20 transplant centers in the U.S., Canada and Europe, including UCSF Medical Center, participated in the phase II clinical trial comparing LEA29Y, also known as BMS-224818, to a similar anti-rejection regimen containing cyclosporine.

"With further clinical study, this may represent a new option to help prevent acute rejection of transplanted kidneys," said Flavio Vincenti, MD, a principal investigator of the trial, who will present the findings on Monday, May 17, 2004, at the American Transplant Congress in Boston. Vincenti is professor of medicine and surgery at the University of California, San Francisco and UCSF Medical Center.

Results of the study show that six months following kidney transplant, LEA29Y was as effective as cyclosporine in preventing acute kidney rejection. However, LEA29Y-treated patients had better kidney function, blood pressure, and total cholesterol levels at six months compared to cyclosporine-treated patients.

"Currently available anti-rejection drugs like cyclosporine are not as selective as this new agent in blocking the immune system," Vincenti said. "These older drugs prevent rejection very well, but they are associated with toxic side effects, including a reduction in kidney function and elevations in blood pressure and cholesterol. This
'"/>

Contact: Janet Basu
jbasu@pubaff.ucsf.edu
415-476-2557
University of California - San Francisco
17-May-2004


Page: 1 2 3 4

Related medicine news :

1. Clinical breast examination offers modest benefit to breast cancer screening program
2. Clinical trial of Etanercept for Wegeners disease shows no benefit
3. Clinical trial participants fare no better, no worse than other patients
4. National Academies news: Clinical research involving children
5. Clinical research key in advance to prospective health care
6. Clinical trial of new TB vaccine begins
7. Clinical trial of Alzheimers disease drug shows clear reductions in AD development
8. Clinical factors useful to identify heart failure patients with high risk of death
9. Panel: Clinical use of embryonic stem cells jeopardized by Bushs policy on federal funding
10. $7 million grant continues Asthma Clinical Research Network efforts
11. Clinical study of Penn State Hershey technology begins in South Africa
Post Your Comments:
(Date:8/21/2008)...trates commitment to industry best practices, meet...ments, MINNEAPOLIS, Aug. 21 /PRNewswire/ -- Natio...th Consulting announces the development of a,compr...lth plans and,pharmacy benefit managers (PBMs) see...zation Review Accreditation Commission (URAC)., T...
(Date:8/21/2008)...ug. 21 /PRNewswire-USNewswire/ -- Bruce Bodaken,C...nia will participate as,a panelist on the 2008 Roc...vention at the start of the Democratic National Co... at Boettcher Hall in the Denver Performing,Arts C... wellness programs,in health reform, and the ways ...
(Date:8/21/2008)...352 on the 2008 Inc. 5,000 list, experiences three...rcent, PORTLAND, Ore., Aug. 21 /PRNewswire/ -- In...nual ranking of the 5,000 fastest-growing private,...st comprehensive look at,one of the most important...minded entrepreneurs., Vigilan delivers operation...
(Date:8/21/2008)... 21 /PRNewswire-USNewswire/ -- Meridian Internatio...former U.S. Assistant Surgeon,General Susan Blumen...Program. The Global Health Program is now a key in... affairs public briefings and conferences, U.S.,St...ograms, and arts and,cultural activities., "Today...
Breaking Medicine News(10 mins):Health News:Halleland Health Consulting Establishes URAC Accreditation Program 2Health News:Blue Shield of California CEO to Speak at Democratic Convention Host Committee's Health Roundtable in Denver 2Health News:Vigilan Recognized as One of the Fastest-Growing Private Companies in the U.S. 2Health News:Former U.S. Assistant Surgeon General, Dr. Susan Blumenthal, to Lead Meridian International Center's Global Health Program 2
Other News:
...nsible for a rare disorder that dramatically eleva...y people at risk for hypertension is the focus of ...rome, first reported in 1963 in a 15-year-old Alab...0 mmHg, says Dr. Yanbin Dong, molecular geneticist...
...are much more likely to suffer from anaemia and hi...with lower birth weights and retarded growth, acco...l Nursing.......A team from the University of Witw...e mothers-to-be with 101 women who had tested nega...
...ude Children's Research Hospital have announced th...t one antigenic variant of the avian influenza vir... of the virus. Vaccines based on this model might ...ng a pandemic (worldwide epidemic) until a new vac...
...patients in Florida's Miami-Dade County are more l...stage of melanoma at the time of diagnosis of the ...f Archives of Dermatology, one of the JAMA/Archive...me increasingly more common, with incidence rates ...
health news:Study looks for genetic predictors of hypertension 2health news:HIV pregnancy study discovers increased anaemia and blood pressure problems 2health news:H5N1 vaccine could be basis for life-saving stockpile 2health news:Hispanics and blacks with melanoma more likely to be diagnosed at a later stage 2
.........</CENTER. An artist's rendering of a glomerular capillary .surrounded by podocyte pedicels which are interconnected by the slit .diaphragm at the capillary-podocyte pedicel interface. ..F
...te immunologists have been awarded grants to. supp... that attack the mucous.membranes. Principal Inve...by.the Mary L. Smith Charitable Lead Trust for her... and Dariusz Kowalczyk, MD, researchers in Dr. Ert...
...ng issued in conjunction with separate news.releas...An antiviral drug administered once daily during f...d B influenza, according to a new study by a.Unive...r. The study appears in.the July 7 issue of the J...
...play a key role in how clever you are? Brain.imagi...ween variations in.thelevels of two brain chemical... say, that changing the balance of the chemicals w...ce a boost... Concentrations of the chemica...
Report in PNAS on role of nephrin, the kidney filter protein 2Report in PNAS on role of nephrin, the kidney filter protein 3Wistar immunologists awarded grants to promote the development of vaccinesagainst HIV-1 and human papilloma viruses 2Inhaled drug useful in preventing flu 2Change your diet and it may make you brighter 2
...and MISSOULA, Mont. May 4, 2005 VaxGen, Inc. (Pi...l Corp. announced today that they have formed a co...t Meningitis serogroup B, using technology develop...of-concept studies during the next 12 months and h...
...team that includes biologists at the University of... genetic blueprint of Dictyostelium discoideum, a ... model genetic system, much like fruit flies and l...human diseases.......The scientific details of thi...
... May 5, 2005 -- A microbial community thriving und...be a gold mine to researchers in their quest to un...how these inner workings might apply on a grander ...Online, researchers from the Department of Energy'...
... University of Washington and their colleagues at ...cantly extend the lifespan of mice while reducing ...h will be published online by the journal Science ...theory of aging. ......The theory suggests that ve...
VaxGen and EndoBiologics form collaboration to pursue early stage research for meningitis B vaccine 2VaxGen and EndoBiologics form collaboration to pursue early stage research for meningitis B vaccine 3Biologists determine genetic blueprint of social amoeba 2Biologists determine genetic blueprint of social amoeba 3ORNL, UC Berkeley unravel real-world clues to Earth's mysteries 2ORNL, UC Berkeley unravel real-world clues to Earth's mysteries 3Researchers extend mouse lifespan by protecting against free radicals 2Researchers extend mouse lifespan by protecting against free radicals 3